Abstract: A torque control apparatus may include an input device, a driving device, a memory, and a controller. For example, the torque control apparatus may be configured to obtain an input related to acceleration of the host vehicle from a user by use of the input device, to determine user requirement torque based on the input, to generate a first requirement torque to be input to the driving device for the acceleration of the host vehicle based on at least part of the user requirement torque, to generate an estimation rate value through the first requirement torque by use of a pitch rate estimation model, and to generate a second requirement torque by use of at least one of the estimation rate value, a requirement rate value, the user requirement torque, or a combination of the estimation rate value, the requirement rate value, and the user requirement torque.

Abstract: A vehicle speed controlling apparatus comprising a driving mode selector configured to receive a selection of a periodic-speed driving mode from a user, a driving strategy control unit including a speed profile generator configured to generate a periodic-speed driving speed profile with a period, an amplitude, and an average speed, and a driving assistance unit configured to output a required torque for a driving motor to follow the periodic-speed driving speed profile.

Abstract: A failure diagnosis method and a failure diagnosis system of a dual purge system may determine whether a closed stuck failure or an opened stuck failure occurs in a line forming a dual purge system by measuring a pressure in a negative pressure formation device and comparing the corresponding pressure with a predetermined reference value when a purge valve of the dual purge system is in an opened or closed state, and may determine whether the failure occurs in components related to a secondary purge line in the dual purge system in which it is difficult to determine whether the failure occurs in a conventional failure diagnosis method of a single purge system in a simple method.

Abstract: A failure diagnosis method and a failure diagnosis system of a dual purge system may determine whether a closed stuck failure or an opened stuck failure occurs in a line forming a dual purge system by measuring a pressure in a negative pressure formation device and comparing the corresponding pressure with a predetermined reference value when a purge valve of the dual purge system is in an opened or closed state, and may determine whether the failure occurs in components related to a secondary purge line in the dual purge system in which it is difficult to determine whether the failure occurs in a conventional failure diagnosis method of a single purge system in a simple method.

Abstract: The present invention relates to a method for inducing and proliferating target virus antigen-specific dual activated T cells, and can produce target virus antigen-specific dual activated T cells by treating monocytes, which are isolated from peripheral blood, with a cytokine and a virus antigen peptide mixture and culturing the same.

Abstract: The present disclosure relates to a composition for preventing or treating graft-versus-host disease (GVHD) containing a TLR5 agonist derived from flagellin as an active ingredient. The TLR5 agonist derived from flagellin according to the present disclosure exhibits an excellent therapeutic effect against GVHD, and thus may be developed as an active ingredient for a composition for the treatment, prevention or alleviation of GVHD.

Abstract: A method of removing impurities from EGR by air blowing may include performing an air-blowing mode in which, when a current intake system pressure detected by a controller exceeds a target intake system pressure in an intake system, in which a mixture is supplied to an engine, a portion of the mixture, serving as compressed air, flows into an EGR path, through which a portion of exhaust, serving as EGR gas and flowing in the intake system and an exhaust system connected to the intake system, is supplied to the engine.

Abstract: The present invention relates to a composition for preventing or treating mucositis comprising NecroX. It was found that NecroX has effects of reducing the disease mortality rate by means of radiotherapy or chemotherapy in a NecroX administration group, protecting intestinal functions, inhibiting destruction of intestinal mucous membrane, and proliferating the cells present in intestines. NecroX may be used for a pharmaceutical composition for preventing or treating mucositis, an anti-cancer adjuvant, or a food composition.

Abstract: The present invention relates to a method for inducing and proliferating target virus antigen-specific dual activated T cells, and can produce target virus antigen-specific dual activated T cells by treating monocytes, which are isolated from peripheral blood, with a cytokine and a virus antigen peptide mixture and culturing the same.

Abstract: A method of removing impurities from EGR by air blowing may include performing an air-blowing mode in which, when a current intake system pressure detected by a controller exceeds a target intake system pressure in an intake system, in which a mixture is supplied to an engine, a portion of the mixture, serving as compressed air, flows into an EGR path, through which a portion of exhaust, serving as EGR gas and flowing in the intake system and an exhaust system connected to the intake system, is supplied to the engine.

Abstract: The present invention relates to a composition for preventing or treating mucositis comprising NecroX. It was found that NecroX has effects of reducing the disease mortality rate by means of radiotherapy or chemotherapy in a NecroX administration group, protecting intestinal functions, inhibiting destruction of intestinal mucous membrane, and proliferating the cells present in intestines. NecroX may be used for a pharmaceutical composition for preventing or treating mucositis, an anti-cancer adjuvant, or a food composition.